Kathryn Moderating At BIO World Congress 2016

Details

Wednesday, 13 April 2016

Sustainability Consult CEO Kathryn Sheridan is moderating ‘Plant-To-Plant… To Brand – The Relay Race To Commercialize Bio-based Products’, a session at the 2016 BIO World Congress on Industrial Biotechnology.  Marcel Lubben, President of our client Reverdia, co-moderates.  The Growing Global Biobased Markets track is on 20 April at 8.30am.  Participants include Hans van der Pol of Corbion and Tom van Aken of Avantium.  This will be Kathryn’s sixth time attending the conference.

Read more ...

Press Release: Evolva To Co-develop Next-generation Materials With US Navy

Details

Tuesday, 12 April 2016

Applications include fire resistant coatings and structural materials for use in aircraft, waterborne craft, fabrics and construction

Evolva (SIX: EVE) announced that it has completed a Limited Purpose Cooperative Research and Development Agreement (CRADA) to support the joint development of novel advanced materials with the US Navy.  The focus of the efforts supported by this CRADA relate to the development, validation and potential commercialisation of new lightweight, fire-resistant composite materials to save lives and reduce harm from fire.

Read more ...

Press Release: Orineo Voted ‘Bio-based Material of the Year 2016’ By Industry Peers

Details

Thursday, 07 April 2016

Belgian SME Orineo won the prestigious Bio-based Material of the Year Award for its bio-based Touch of Nature® materials at the 9th International Conference on Bio-based Materials in Cologne, Germany, organised by the Nova-institut.

Selected by over 200 industry experts, Touch of Nature® was recognised for its innovative character and functional validity. The material has already been used successfully in a range of design projects where environmental credentials were valued, for example as a bio-based countertop at the OR Coffee shop in Ghent, Belgium. 

Read more ...

Press Release: Evolva Gains Exclusive License To Develop And Commercialise Nootkatone Globally For Pest Control

Details

Tuesday, 05 April 2016

Evolva also signs broader nootkatone collaboration agreement with CDC

Evolva (SIX:EVE) announces that it has just signed a license agreement with the US Centers for Disease Control and Prevention (CDC) that grants Evolva the exclusive worldwide patent rights to develop and commercialise nootkatone for the control of a wide range of disease and virus vectors such as ticks, mosquitoes, fleas, flies, lice, bed bugs, and other biting insects.

Read more ...

Press Release: Evolva Expanding Its Nootkatone Research To Include Mosquitoes That Transmit Zika And Other Viruses

Details

Thursday, 24 March 2016

Data show potential for nootkatone to kill and repel mosquitoes that transmit Zika

Evolva (SIX:EVE) announces that it is expanding its current work with the US Centers for Disease Control (CDC) to research nootkatone’s effectiveness in tick-control to include an additional focus on mosquitoes, including those that transmit Zika, chikungunya, dengue, and West Nile viruses.  CDC research has shown nootkatone both repels and kills the yellow fever mosquito, Aedes aegypti, and the black-legged tick, Ixodes scapularis which transmits Lyme disease.

Read more ...